Start by throwing out three names

Ask Google for Reveleer alternatives today and the AI answer names Apixio, Episource, and Pulse8. All three are out of date, and two of them stopped being independent companies years ago.

This is what makes vendor lists in this category dangerous. Risk adjustment and quality software has consolidated hard since 2023, and most of the pages ranking for these queries were written before the deals closed or were assembled by scraping each other.

What Reveleer is, so you know what you are replacing

Reveleer started in 2009 as Health Data Vision, a medical record retrieval services business, and took the Reveleer name in August 2019. It is a health plan platform. Its retrieval engine runs three lanes: digital EHR integration, a provider upload portal, and mail and fax. On top of that sit retrospective and prospective risk adjustment, HEDIS abstraction and hybrid audit support, a care gap program the plan owns and invites provider groups into, a dedicated RADV Audit product launched October 2025, and Member Management, which is Medicare Advantage enrollment, premium billing, and revenue reconciliation.

Three acquisitions built most of the newer surface area: MDPortals in May 2023, Curation Health in October 2024, and Novillus in April 2025. EVE Hybrid AI, its diagnosis-suspecting engine on Google Cloud, launched January 2026. If you read a page calling Reveleer a retrospective chart review vendor, that page is describing 2024.

Why buyers go looking

Every reason below traces to something Reveleer publishes about itself, not to a complaint. There is no aggregated buyer sentiment about Reveleer anywhere, which is a problem in its own right and gets its own section further down.

  • You need a certified HEDIS measure engine. Reveleer does not run one. Its quality product integrates with whichever certified engine the plan already uses. If the engine is the purchase, Reveleer is the wrong shelf.
  • You are provider-side. Reveleer's care gap program is owned by the health plan, and Member Management is described as purpose-built for MA plans. A delegated IPA working five payer contracts is not the buyer that product line was designed around.
  • You need the outreach performed, not routed. Care Gap Manager builds packets and web forms for provider office staff. Someone still places the call.
  • You want a product rated for the exam room. Reveleer's prospective offering is real and current, but the independent point-of-care ratings in 2025 and 2026 went to other vendors.

The alternatives, by job

Reveleer is four products to four buyers, so nobody replaces all of it. This table maps the job to the shortlist. The sections after it give one sourced paragraph per vendor: what it is, when it beats Reveleer, and where it is weaker.

The jobReveleer's productAlternatives worth a call
Get the charts, code themRetrieval, Retrospective Risk AdjustmentDatavant, Episource (Optum-owned)
Catch the condition before the visitClinical Intelligence, EVE Hybrid AINavina, Cozeva (Vatica Health), Edifecs (a Cotiviti business)
Measure quality on a certified engineNone. Reveleer integrates with yours.Inovalon, Cotiviti, Innovaccer, Arcadia, Astrata
Work the gap after it is identifiedCare Gap ManagerPelica, Innovaccer, Cotiviti Engagement Hub, Inovalon
Survive the auditRADV Audit SaaSInovalon, Datavant
Run the MA back officeMember ManagementOut of scope for this page. See the note below.

Job 1: chart retrieval and abstraction at scale

Datavant is the strongest name here on independent evidence. It won 2026 Best in KLAS for Risk Adjustment (Coding, Retrieval and Compliance Solutions) at 90.5 and Outsourced Coding at 94.9, and it absorbed Apixio's value-based care suite in September 2024. The release cites 4.5 million charts coded annually and 98% coding accuracy. It beats Reveleer when retrieval volume, coding throughput, and an independent quality signal are what you are buying. It is weaker as a workflow platform: Datavant is a data-exchange and coding company, without a care gap execution product or a quality abstraction suite of Reveleer's breadth.

Episource runs end-to-end retrospective risk adjustment with a deep services bench and Optum-scale delivery. It has been owned by Optum since 2023, which is either a non-issue or a deal-breaker depending on whether your plan competes with UnitedHealth. Weigh the 2025 breach disclosure alongside it.

Two other names come up in retrieval conversations because of what sits next to them. Cotiviti completed its acquisition of Edifecs on March 31, 2025, which puts encounter and interoperability pipes next to its quality and payment integrity work. Inovalon works the measurement and audit-readiness end and does not chase charts. Neither is a like-for-like swap for Reveleer's retrieval lanes.

Job 2: prospective risk suspecting

Navina is a clinician-first AI copilot that summarizes the patient and surfaces suspected conditions inside the EHR at the point of care. It raised a $55M Series C in March 2025 led by Growth Equity at Goldman Sachs Alternatives, and ranked #1 Best in KLAS for Clinician Digital Workflow in 2025. For physician groups and ACOs whose main lever is the visit itself, it is the stronger buy. It is not a chart review, retrieval, or audit submission engine, and it does not do RADV. We compare the two directly in Navina vs Reveleer.

Cozeva, now part of Vatica Health after a merger that closed October 31, 2025, won 2026 Best in KLAS for Risk Adjustment: Point of Care and In-Home Health Assessments at 91.2. On the point-of-care job specifically it wins, and it adds an in-home assessment arm Reveleer does not have. The trade is a services-heavy delivery model and no plan-side retrieval or HEDIS abstraction platform.

Edifecs, a Cotiviti business, launched Point of Care Suspects in March 2025. It wins on bundle economics: if the plan already runs Edifecs for interoperability and encounter management, suspects arrive through a pipe that exists. It is newer at suspecting, and the case rests on the bundle more than on the exam-room product itself.

For context on what you would be replacing: Reveleer's own prospective product is not a weak spot. Clinical Intelligence cites 11,000 clinical indicators plus clinician-authored formulas, and EVE Hybrid AI shipped in January 2026.

Job 3: certified HEDIS measurement

Read this framing before the vendors. Reveleer is not in this job at all. It integrates with whichever certified engine you run, so replacing Reveleer with an engine vendor is a category error unless the engine is what you actually needed.

Inovalon Converged Quality is the deepest bench here. It won 2026 Best in KLAS for Quality Measurement and Reporting (Payer) and announced its 26th consecutive NCQA HEDIS certification plus NCQA validation of its digital quality measure engine on July 23, 2026, citing 100-plus plans, 12 of the top 15, and 209 million lives. It also competes with Reveleer on RADV. Its heritage is measurement and readiness; gap closure is newer, announced October 2025.

Cotiviti Quality Intelligence is the most credible digital-measure story if the 2030 dQM transition is your buying trigger. It certified for all available NCQA digital HEDIS measures for MY2025 in June 2026, on top of a 25th consecutive HEDIS certification in July 2025. It also ships Engagement Hub for member outreach, with Eliza reaching more than 50 million members. The cost is enterprise payer scale and the procurement cycle that comes with it.

Innovaccer InGraph is listed by NCQA as certified for all HEDIS Health Plan measures for MY2026, and its Galaxy payer platform scored 90.5 in 2026 Best in KLAS for payer data analytics. It fits a buyer who wants certified measurement and an enterprise data platform from one vendor. Platform breadth means a longer implementation. We cover it at length in Innovaccer alternatives.

Arcadia Quality Plus is also NCQA certified for all HEDIS Health Plan measures for MY2026, with provider-side and network analytics depth Reveleer does not have. Nordic Capital took a majority stake in July 2025. It is an analytics platform, and its own 2026 survey reports that only 14% of leaders have AI fully embedded in decision points, which describes the workflow problem rather than solving it.

Astrata is the specialist option, and it is small. Its eMeasure product is listed as seeking certification for MY2026, it became an ACAP preferred vendor in July 2025, and NCQA founder Margaret O'Kane joined its board in February 2026. Medicaid plans that want unusually deep NCQA lineage should look. It has no retrieval or RADV product. Our HEDIS and Stars buyer's guide goes deeper on this group.

One caution that applies to this whole section. NCQA's certification list lags announcements, so absence from the list is not evidence a vendor failed anything. Make positive statements only about vendors that appear as certified, and ask each one for its current certification letter.

Job 4: working the gap after it is identified

Pelica is the alternative when the gap list is already good and the constraint is a six to ten person team against a 50,000 to 150,000 member panel. It builds one canonical member record from claims, EHR, pharmacy, lab, ADT, and payer feeds, then runs agents that place the call, work the payer portal, follow up, and escalate only when a person is genuinely needed. Live in about two weeks. This is the only job where we would put Pelica ahead of Reveleer, and the limits are listed plainly further down.

Innovaccer is the most direct competitor on execution and the only vendor publicly repricing toward work done rather than software access, with per-task pricing announced in April 2026 at roughly $20 per prior authorization against roughly $100 manual. It ships 50-plus pre-built Gravity agents and a Care Management Copilot. Buyers who want execution inside an enterprise data platform should take it over Reveleer. Implementation runs on enterprise timelines, and it holds no 2026 KLAS win in care management.

Cotiviti Engagement Hub and Inovalon Integrated Care Gap Closure both address gap closure from the plan side. Engagement Hub is campaign outreach at real volume across screenings, pediatric checkups, immunizations, diabetes, and hypertension. Integrated Care Gap Closure, announced October 2025, is a coordination layer over fragmented gap programs. Campaign delivery to a member list and a worked queue with escalation and evidence write-back are different products, and the demo question that separates them is who places the second call.

For fairness on the incumbent: Reveleer's Care Gap Manager is a genuine product for a genuine problem. It states 40% higher supplemental data submissions, and it wins where the constraint is provider-office cooperation and supplemental data capture.

Job 5: surviving a RADV audit

Reveleer is a leader here, and pretending otherwise would make the rest of this page worthless. Its RADV Audit SaaS, launched October 2025, runs CMS enrollee data list ingestion, record chasing, HCC validation per payment year, provider attestation with multi-level QA and audit logs, and a CMS-ready submission package.

Two credible alternatives. Inovalon's RADV Audit Readiness Solution was top-ranked by Black Book across 18 performance indicators for the end-to-end MA risk adjustment lifecycle in June 2025. Datavant earns a place on retrieval and coding strength in the KLAS category that includes compliance. Pelica does not belong in this section and is not listed in it.

What this page does not cover

Reveleer's Member Management competes in Medicare Advantage back office: enrollment, CMS election submissions, premium billing, revenue reconciliation. We did not research alternatives in that category, so we are not going to improvise a list. If that is the module you are replacing, this page will not help you.

The evidence problem nobody else mentions

Before you weigh any list, including this one, know how thin the independent evidence is. Reveleer has no G2 product page, and its Capterra listing carries zero reviews, no star rating, and no pricing. We found no meaningful TrustRadius review corpus either. One aggregator publishes a Reveleer alternatives page whose alternatives are Oracle Fusion Cloud ERP, Workiva, and Splunk, which tells you how these pages get built.

So any page claiming to summarize what users say about Reveleer is inventing it. The one independent buyer-derived signal that exists is KLAS, which lists a segment score of 75.0 for the Reveleer Risk Adjustment Solution, flagged as limited data and drawn from four unique organizations, against a category market average of 75.5 and a software average of 80.1, for the data window August 2025 to August 2026. Reveleer holds no Best in KLAS award in that category, where Datavant won 2026 at 90.5. Four organizations is a signal, not a rating, and it should not be used as one.

Pelica has no KLAS rating at all. We are naming a competitor's independent score, so it would be a double standard not to say that in the same breath.

Pricing

Nobody in this category publishes it, Reveleer included. Neither Capterra nor any procurement aggregator we checked lists a Reveleer starting price, free trial, or free tier as of August 2026. Pricing is quoted per engagement, so the useful move is to standardize what you ask every vendor for: cost per closed gap, cost per retrieved chart, cost per validated HCC, and what happens to the unit price when volume doubles. Third-party guides have started publishing cost-per-closed-gap benchmarks in the range of a few dollars to roughly eleven, which is enough to make the question answerable in a first call.

Where Pelica fits, and where it does not

Start with what we do not do, because it removes us from most of this page. There is no chart retrieval network, no RADV submission product, no Medicare Advantage enrollment or billing back office, and no certified HEDIS measure engine. We have no KLAS rating, and we are a much smaller company than every other vendor named here.

What is left is one job: closing gaps across payer contracts from the provider side, after somebody else has identified them. Pelica unifies claims, EHR, pharmacy, lab, ADT, and payer feeds into one canonical member record, typically replacing 8 to 15 vendor portals, then runs voice and computer-use agents that call patients, pharmacies, and prescribers, work payer portals and EHRs, follow up, and escalate to a coordinator when the situation needs one.

96 to 98%
Adherence on the three triple-weighted Part D measures
70%+
Transitions-of-care gaps closed within 30 days
2 weeks
From kickoff to live, on your existing feeds

At our flagship customer, a physician-led IPA in New York running risk on about 175,000 patients, adoption reached 100% and teams got back roughly 10 hours per user per week. Roughly 90% of BCS and KED gaps close in-year. Risk adjustment coordination went from 30 minutes to 3 per member. Pelica is SOC 2 Type II, HIPAA compliant, and signs a BAA. If your problem is getting charts out of unaffiliated provider offices, none of that helps you and Reveleer is the better call. We lay the comparison out row by row in Pelica vs Reveleer.

Check the date on any list like this one

This page is dated August 4, 2026, and that date is load-bearing. In the last three years Apixio went into Datavant, Episource went into Optum, Edifecs went into Cotiviti, Cozeva merged into Vatica Health, Reveleer bought MDPortals, Curation Health, and Novillus, and Innovaccer bought PQS and a revenue cycle business. Inovalon and Cotiviti both changed CEOs. Any vendor list written before those closed is describing a market that no longer exists, and half the pages ranking for this query were.

When you read a comparison, ours included, check three things: the publication date, whether the vendor descriptions cite the vendor's own current product pages, and whether the page names a single independent rating with its sample size attached. Most of them fail all three.

Sources